Overdose reversal medication could soon be sold alongside ibuprofen and allergy meds, but cost may still be a barrier

By WHYY
| February 26, 2023

An advisory committee for the FDA unanimously voted last week to support a nonprescription version of Narcan's nasal spray. But the list price could still pose a barrier.

Full story

#1

Physicians are in short supply. They are costly. Is the APP the answer to the CMO's workforce and budget challenges? ...

Amid the hype and promise, a growing tension is becoming clear: the reality of what AI can deliver versus what it can't. ...